| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 29 |
| 1 | DEXAMETHASONE | 21 |
| 2 | DEXAMETHASONE 1.5 MG | 21 |
| 3 | MYCOPHENOLATE MOFETIL | 18 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 18 |
| 5 | PREDNISONE | 16 |
| 6 | NIVOLUMAB | 12 |
| 7 | ACETAMINOPHEN | 8 |
| 8 | SPIRONOLACTONE | 8 |
| 9 | CYCLOPHOSPHAMIDE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DASPONE | 7 | 0.0007 |
| 1 | DAPSONE GEL, 5% | 7 | 0.0007 |
| 2 | DAPSONE | 7 | 0.0006 |
| 3 | CARBOXYMETHYLCELLULOSE SODIUM | 3 | 0.0005 |
| 4 | TRANEXAMIC ACID | 4 | 0.0004 |
| 5 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 2 | 0.0004 |
| 6 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 1 | 0.0004 |
| 7 | LOTEPREDNOL ETABONATE | 2 | 0.0004 |
| 8 | SITAGLIPTIN PHOSPHATE | 1 | 0.0004 |
| 9 | VANCOMYCIN HYDROCHLORIDE | 3 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sulfone [EPC] | 7 | 0.0006 |
| 1 | beta Lactamase Inhibitor [EPC] | 2 | 0.0004 |
| 2 | Anthracycline Topoisomerase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Antifibrinolytic Agent [EPC] | 4 | 0.0004 |
| 4 | Human Immunoglobulin G [EPC] | 7 | 0.0003 |
| 5 | Adenosine Receptor Agonist [EPC] | 2 | 0.0003 |
| 6 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 7 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 5 | 0.0002 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 12 | 0.0001 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 30 | 0.0001 |